Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

被引：0
|
作者：
Chandra R Tate
Lyndsay V Rhodes
H Chris Segar
Jennifer L Driver
F Nell Pounder
Matthew E Burow
Bridgette M Collins-Burow
机构：
[1] Tulane University Health Sciences Center,Department of Medicine, Section of Hematology and Medical Oncology
来源：
Breast Cancer Research | / 14卷
关键词：
Panobinostat; LBH589; triple-negative breast cancer; xenograft; histone deacetylase inhibitor; E-cadherin; CDH1; epithelial-to-mesenchymal transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The response of histone deacetylase inhibitors in triple negative breast cancer
    Alzoubi, Madlin
    Nguyen, Khoa
    Burks, Hope
    Hebert, Katherine
    Cheng, Thomas
    Matossian, Margarite
    Wright, Maryl
    Collins-Burow, Bridgette
    Burow, Matthew
    CANCER RESEARCH, 2022, 82 (04)
  • [22] Therapeutic Effect of Histone Deacetylase Inhibitor Panobinostat on Human Esophageal Cancer Cells
    Chen, Y.
    Chi, C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S546 - S547
  • [23] Unexpected selectivity of histone deacetylase inhibitors in live MDA-MD-231 triple-negative breast cancer cells
    Aboukhatwa, Shaimaa M.
    Hanigan, Thomas W.
    Neerasa, Jayaprakash
    Taha, Taha Y.
    Brown, Nathan D.
    El-Bastawissy, Eman E.
    Elkersh, Mohamed A.
    El-Moselhy, Tarek F.
    Frasor, Jonna
    Petukhov, Pavel A.
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer
    Jiang, Xin-Chen
    Tu, Fang-Hai
    Wei, Li-Yuan
    Wang, Bo-Zheng
    Yuan, Hao
    Yuan, Jing-Mei
    Rao, Yong
    Huang, Shi-Liang
    Li, Qing-Jiang
    Ou, Tian-Miao
    Wang, Hong-Gen
    Tan, Jia-Heng
    Chen, Shuo-Bin
    Huang, Zhi-Shu
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 12346 - 12366
  • [25] Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients
    Uzelac, Bojana
    Krivokuca, Ana
    Susnjar, Snezana
    Milovanovic, Zorka
    Supic, Gordana
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2021, 25 (03) : 227 - 235
  • [26] A New Histone Deacetylase Inhibitor Enhances Radiation Sensitivity through the Induction of Misfolded Protein Aggregation and Autophagy in Triple-Negative Breast Cancer
    Chiu, Hui-Wen
    Yeh, Ya-Ling
    Ho, Sheng-Yow
    Wu, Yuan-Hua
    Wang, Bour-, Jr.
    Huang, Wei-Jan
    Ho, Yuan-Soon
    Wang, Ying-Jan
    Chen, Li-Ching
    Tu, Shih-Hsin
    CANCERS, 2019, 11 (11)
  • [27] Molecular mechanisms of bifunctional vitamin D receptor agonist-histone deacetylase inhibitor hybrid molecules in triple-negative breast cancer
    Barbier, Camille
    Mansour, Ali
    Ismailova, Aiten
    Sarmadi, Fatemeh
    Scarlata, David A.
    Bouttier, Manuella
    Zeitouni, Camille
    Wang, Catherine
    Gleason, James L.
    White, John H.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Molecular mechanisms of bifunctional vitamin D receptor agonist-histone deacetylase inhibitor hybrid molecules in triple-negative breast cancer
    Camille Barbier
    Ali Mansour
    Aiten Ismailova
    Fatemeh Sarmadi
    David A. Scarlata
    Manuella Bouttier
    Camille Zeitouni
    Catherine Wang
    James L. Gleason
    John H. White
    Scientific Reports, 12
  • [29] Targeting triple-negative breast cancer: A clinical perspective
    Popovic, Lazar S.
    Matovina-Brko, Gorana
    Popovic, Maja
    Punie, Kevin
    Cvetanovic, Ana
    Lambertini, Matteo
    ONCOLOGY RESEARCH, 2023, 31 (03) : 221 - 238
  • [30] Epigenetic reprogramming of epithelial-mesenchymal transition in triple-negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
    Su, Yanrong
    Hopfinger, Nathan R.
    Pogash, Thomas J.
    Nguyen, Theresa D.
    Santucci-Pereira, Julia
    Russo, Jose
    CANCER RESEARCH, 2014, 74 (19)
12345